Solara Active Pharma Sciences Ltd - SOLARA ACTIVE Share Price

Sector: Pharmaceuticals | ISIN: INE624Z01016
₹ 534.00 (12.71%) icon19 Apr, 2024, 1:19:59 PM
Open
₹ 470.00
Prev. Close
₹ 473.80
Turnover(lac)
₹ 0.18
Day's High
₹ 534.35
Day's Low
₹ 461.25
52 Wk High
₹ 506.50
52 Wk Low
₹ 286.00
Book Value
₹ 331.33
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 1,922.20
P/E
0.00
EPS
0.00
Div. Yield
0.63

Solara Active Pharma Sciences Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/19/2024 1:19:59 PM

    ₹ 534 60.20 12.71
  • Open
  • ₹ 470
  • Prev. Close
  • ₹ 473.8
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 534.35
  • Day's Low
  • ₹ 461.25
  • 52 Week's High
  • ₹ 506.5
  • 52 Week's Low
  • ₹ 286
  • Book Value
  • ₹ 331.33
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 1,922.2
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0.63

Solara Active Pharma Sciences Ltd Corporate Actions

05 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Feb , 2024

12:00 AM

07 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Nov , 2023

12:00 AM

19 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Aug , 2023

12:00 AM

AGM

Announcement date: 21 Aug , 2023

View Details

04 Aug , 2023

12:00 AM

04 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Solara Active Pharma Sciences Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Solara Active Pharma Sciences Ltd SHAREHOLDING SNAPSHOT
19 April , 2024 | 01:39 PM

PROMOTER - TOTAL30.49%

Indian: 30.49%

Foreign: 0%

NON-PROMOTER - TOTAL 69.51%

Institutions: 18.78%

Non-Institutions: 50.74%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Solara Active Pharma Sciences Ltd FINANCIALS

Solara Active Pharma Sciences Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Solara Active Pharma Sciences Ltd

  • Aditya Puri
  • Chairman & Non Executive Dir.
  • Nirmal P Bhogilal
  • Independent Non Exe. Director
  • Vineeta Rai
  • Independent Non Exe. Director
  • RAJAGOPALAN RAMAKRISHNAN
  • Independent Non Exe. Director
  • Kausalya Santhanam
  • Independent Non Exe. Director
  • ANKUR NAND THADANI
  • Non Executive Director
  • Arun Kumar
  • Non Executive Director
  • S Hariharan
  • Executive Director & CFO
  • Jitesh Devendra
  • Managing Director & CEO
  • Poorvank Purohit
  • Managing Director & CEO
  • Rajendra Kumar Srivastava
  • Additional Director
  • Rajiv Vijay Naba
  • Additional Director

Summary

Solara Active Pharma Sciences Ltd is a Public Limited Company incorporated in February 23, 2017 under the provisions of Companies Act, 2013 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has six APIs manufacturing plants located in Ambernath, Mangalore, Mysore, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,000 kilo litres and two R&D Centres in Chennai and Bangalore. The business is spread across 75 countries globally with extensive operations in key markets of North America, Europe, Japan, South Korea, the Middle East and North Africa.The Company offer rich basket of niche high-value products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others. It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches. Apart from this, the Solara Active has two research and development units - in Bengaluru and Chennai - equipped with state-of-the-art facilities and a pipeline of 25+ products, at different stages of development. These drugs primarily deal with anthelmintic, anti-malarias, beta blockers,muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.The Companys... Read More


Reports by Solara Active Pharma Sciences Ltd


Reports by Solara Active Pharma Sciences Ltd

Company FAQ

No Record Found